Insulin prices have skyrocketed in recent years, working a hardship on the growing number of diabetics in the US. Progressive ...
Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...
Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason for the sharp ...
Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...
A new ad playing on TV, endorsed by Kaine, says he worked to lower insulin prices. We verify that claim before Election Day.
It has also reported shortages of NovoLog, another insulin product. The drugmakers run patient assistance programs that cap ...
It has also reported shortages of NovoLog, another insulin product. The drugmakers run patient assistance programs that cap prices at $35 or under, but can be hard to access for both patients and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback